Use of cobratoxin as an analgesic
AssigneeReceptopharm, Inc.
InventorsPaul Reid, Zheng Qin
Life of this patent
Estimating the term…
Abstract
A composition of matter for an analgesia and its method of use is disclosed. The method of use is for the treatment of chronic pain, especially to the treatment of heretofore intractable pain as associated with advanced cancer. The pain associated with neurological conditions, rheumatoid arthritis, viral infections and lesions is also contemplated. The method includes administering to a host an alpha-neurotoxin that is characterized by its ability to blocking of the action of acetylcholine at nicotinic acetylcholine receptors.
Claims5
A method of treatment of pain in a host by administering a pharmaceutical composition of matter comprising a therapeutically effective amount of cobratoxin and a pharmaceutically acceptable carrier base for use in inhibiting or controlling pain.
A method of treatment of a host comprising one of animals and humans experiencing pain comprising administering to the host a mitigating amount of an alpha-cobratoxin composition one of parenterally, topically and orally.
Dependencies are inferred from the claim text.